193 related articles for article (PubMed ID: 36053908)
41. Chemical modification of the inner and outer surfaces of Tobacco Mosaic Virus (TMV).
Bruckman MA; Steinmetz NF
Methods Mol Biol; 2014; 1108():173-85. PubMed ID: 24243249
[TBL] [Abstract][Full Text] [Related]
42. Modulation of cisplatin sensitivity in human ovarian carcinoma A2780 and SKOV3 cell lines by sulforaphane.
Hunakova L; Gronesova P; Horvathova E; Chalupa I; Cholujova D; Duraj J; Sedlak J
Toxicol Lett; 2014 Nov; 230(3):479-86. PubMed ID: 25159039
[TBL] [Abstract][Full Text] [Related]
43. The targeted SMAC mimetic SW IV-134 augments platinum-based chemotherapy in pre-clinical models of ovarian cancer.
Binder PS; Hashim YM; Cripe J; Buchanan T; Zamorano A; Vangveravong S; Mutch DG; Hawkins WG; Powell MA; Spitzer D
BMC Cancer; 2022 Mar; 22(1):263. PubMed ID: 35279106
[TBL] [Abstract][Full Text] [Related]
44. NCX-4040, a nitric oxide-releasing aspirin, sensitizes drug-resistant human ovarian xenograft tumors to cisplatin by depletion of cellular thiols.
Bratasz A; Selvendiran K; Wasowicz T; Bobko A; Khramtsov VV; Ignarro LJ; Kuppusamy P
J Transl Med; 2008 Feb; 6():9. PubMed ID: 18302761
[TBL] [Abstract][Full Text] [Related]
45. cis-Amminedichloro(2-methylpyridine) platinum(II) (AMD473), a novel sterically hindered platinum complex: in vivo activity, toxicology, and pharmacokinetics in mice.
Raynaud FI; Boxall FE; Goddard PM; Valenti M; Jones M; Murrer BA; Abrams M; Kelland LR
Clin Cancer Res; 1997 Nov; 3(11):2063-74. PubMed ID: 9815598
[TBL] [Abstract][Full Text] [Related]
46. Tobacco mosaic virus rods and spheres as supramolecular high-relaxivity MRI contrast agents.
Bruckman MA; Hern S; Jiang K; Flask CA; Yu X; Steinmetz NF
J Mater Chem B; 2013 Mar; 1(10):1482-1490. PubMed ID: 23589767
[TBL] [Abstract][Full Text] [Related]
47. Tobacco mosaic virus for the targeted delivery of drugs to cells expressing prostate-specific membrane antigen.
Shukla S; Marks I; Church D; Chan SK; Pokorski JK; Steinmetz NF
RSC Adv; 2021 Jun; 11(33):20101-20108. PubMed ID: 34178308
[TBL] [Abstract][Full Text] [Related]
48. Sequential combination of cisplatin with eugenol targets ovarian cancer stem cells through the Notch-Hes1 signalling pathway.
Islam SS; Aboussekhra A
J Exp Clin Cancer Res; 2019 Aug; 38(1):382. PubMed ID: 31470883
[TBL] [Abstract][Full Text] [Related]
49. Cisplatin-induced immune modulation in ovarian cancer mouse models with distinct inflammation profiles.
Grabosch S; Bulatovic M; Zeng F; Ma T; Zhang L; Ross M; Brozick J; Fang Y; Tseng G; Kim E; Gambotto A; Elishaev E; P Edwards R; Vlad AM
Oncogene; 2019 Mar; 38(13):2380-2393. PubMed ID: 30518877
[TBL] [Abstract][Full Text] [Related]
50. Combination of ciglitazone, a peroxisome proliferator-activated receptor gamma ligand, and cisplatin enhances the inhibition of growth of human ovarian cancers.
Yokoyama Y; Xin B; Shigeto T; Mizunuma H
J Cancer Res Clin Oncol; 2011 Aug; 137(8):1219-28. PubMed ID: 21681689
[TBL] [Abstract][Full Text] [Related]
51. TMV-Based Adapter Templates for Enhanced Enzyme Loading in Biosensor Applications.
Koch C; Poghossian A; Wege C; Schöning MJ
Methods Mol Biol; 2018; 1776():553-568. PubMed ID: 29869265
[TBL] [Abstract][Full Text] [Related]
52. Intraperitoneal delivery of platinum with in-situ crosslinkable hyaluronic acid gel for local therapy of ovarian cancer.
Cho EJ; Sun B; Doh KO; Wilson EM; Torregrosa-Allen S; Elzey BD; Yeo Y
Biomaterials; 2015 Jan; 37():312-9. PubMed ID: 25453960
[TBL] [Abstract][Full Text] [Related]
53. Enhanced antitumor efficacy of a DR5-specific TRAIL variant over recombinant human TRAIL in a bioluminescent ovarian cancer xenograft model.
Duiker EW; de Vries EG; Mahalingam D; Meersma GJ; Boersma-van Ek W; Hollema H; Lub-de Hooge MN; van Dam GM; Cool RH; Quax WJ; Samali A; van der Zee AG; de Jong S
Clin Cancer Res; 2009 Mar; 15(6):2048-57. PubMed ID: 19276284
[TBL] [Abstract][Full Text] [Related]
54. The Impact of the Low Molecular Weight Heparin Tinzaparin on the Sensitization of Cisplatin-Resistant Ovarian Cancers-Preclinical In Vivo Evaluation in Xenograft Tumor Models.
Mueller T; Pfankuchen DB; Wantoch von Rekowski K; Schlesinger M; Reipsch F; Bendas G
Molecules; 2017 May; 22(5):. PubMed ID: 28467373
[TBL] [Abstract][Full Text] [Related]
55. Costunolide induces apoptosis in platinum-resistant human ovarian cancer cells by generating reactive oxygen species.
Yang YI; Kim JH; Lee KT; Choi JH
Gynecol Oncol; 2011 Dec; 123(3):588-96. PubMed ID: 21945308
[TBL] [Abstract][Full Text] [Related]
56. PG545 enhances anti-cancer activity of chemotherapy in ovarian models and increases surrogate biomarkers such as VEGF in preclinical and clinical plasma samples.
Winterhoff B; Freyer L; Hammond E; Giri S; Mondal S; Roy D; Teoman A; Mullany SA; Hoffmann R; von Bismarck A; Chien J; Block MS; Millward M; Bampton D; Dredge K; Shridhar V
Eur J Cancer; 2015 May; 51(7):879-892. PubMed ID: 25754234
[TBL] [Abstract][Full Text] [Related]
57. Effects of the tom1 mutation of Arabidopsis thaliana on the multiplication of tobacco mosaic virus RNA in protoplasts.
Ishikawa M; Naito S; Ohno T
J Virol; 1993 Sep; 67(9):5328-38. PubMed ID: 8350399
[TBL] [Abstract][Full Text] [Related]
58. Exosome release and low pH belong to a framework of resistance of human melanoma cells to cisplatin.
Federici C; Petrucci F; Caimi S; Cesolini A; Logozzi M; Borghi M; D'Ilio S; Lugini L; Violante N; Azzarito T; Majorani C; Brambilla D; Fais S
PLoS One; 2014; 9(2):e88193. PubMed ID: 24516610
[TBL] [Abstract][Full Text] [Related]
59. Synthetic chloroinconazide compound exhibits highly efficient antiviral activity against tobacco mosaic virus.
Lv X; Xiang S; Wang X; Wu L; Liu C; Yuan M; Gong W; Win H; Hao C; Xue Y; Ma L; Cheng D; Sun X
Pest Manag Sci; 2020 Nov; 76(11):3636-3648. PubMed ID: 32418274
[TBL] [Abstract][Full Text] [Related]
60. Cisplatin-loaded core cross-linked micelles: comparative pharmacokinetics, antitumor activity, and toxicity in mice.
Oberoi HS; Nukolova NV; Laquer FC; Poluektova LY; Huang J; Alnouti Y; Yokohira M; Arnold LL; Kabanov AV; Cohen SM; Bronich TK
Int J Nanomedicine; 2012; 7():2557-71. PubMed ID: 22745537
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]